Stem Cell Therapy Market Report

Global and Region Stem Cell Therapy Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：222
  • REPORT CODE：GMM891934
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Stem Cell Therapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Stem Cell Therapymarket, defines the market attractiveness level of Stem Cell Therapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Stem Cell Therapy industry, describes the types of Stem Cell Therapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Stem Cell Therapy market and the development prospects and opportunities of Stem Cell Therapy industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Stem Cell Therapy market in Chapter 13.

    By Player:

    • CELGENE CORPORATION

    • ReNeuron Group plc

    • Virgin Health Bank

    • Biovault family

    • Precious Cells International Ltd

    • Mesoblast Ltd

    • Astellas Pharma Inc

    • Seneca Biopharmaceuticals, Inc

    • Opexa Therapeutics, Inc

    • Pluristem Therapeutics Inc

    • STEMCELL Technologies Inc

    • ThermoGenesis Holdings, Inc

    • Chiesi Pharmaceuticals

    • Cellular Engineering Technologies

    • BioTime, Inc

    By Type:

    • Autologous

    • Allogeneic

    By End-User:

    • Musculoskeletal Disorder

    • Wounds & Injuries

    • Cornea

    • Cardiovascular Diseases

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Stem Cell Therapy Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Stem Cell Therapy Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Stem Cell Therapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Stem Cell Therapy Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Stem Cell Therapy Market Analysis and Outlook to 2022

    • 7.1 Global Stem Cell Therapy Consumption (2017-2022)

    • 7.2 United States Stem Cell Therapy Consumption (2017-2022)

    • 7.3 Europe Stem Cell Therapy Consumption (2017-2022)

    • 7.4 China Stem Cell Therapy Consumption (2017-2022)

    • 7.5 Japan Stem Cell Therapy Consumption (2017-2022)

    • 7.6 India Stem Cell Therapy Consumption (2017-2022)

    • 7.7 South Korea Stem Cell Therapy Consumption (2017-2022)

    8 Region and Country-wise Stem Cell Therapy Market Analysis and Outlook to 2028

    • 8.1 Global Stem Cell Therapy Consumption Forecast (2022-2028)

    • 8.2 United States Stem Cell Therapy Consumption Forecast (2022-2028)

    • 8.3 Europe Stem Cell Therapy Consumption Forecast (2022-2028)

    • 8.4 China Stem Cell Therapy Consumption Forecast (2022-2028)

    • 8.5 Japan Stem Cell Therapy Consumption Forecast (2022-2028)

    • 8.6 India Stem Cell Therapy Consumption Forecast (2022-2028)

    • 8.7 South Korea Stem Cell Therapy Consumption Forecast (2022-2028)

    9 Global Stem Cell Therapy Market Outlook by Types and Applications to 2022

    • 9.1 Global Stem Cell Therapy Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Autologous Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Allogeneic Consumption and Growth Rate (2017-2022)

    • 9.2 Global Stem Cell Therapy Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Musculoskeletal Disorder Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Wounds & Injuries Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cornea Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Stem Cell Therapy Market Outlook by Types and Applications to 2028

    • 10.1 Global Stem Cell Therapy Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Autologous Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Allogeneic Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Stem Cell Therapy Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Musculoskeletal Disorder Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Wounds & Injuries Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cornea Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Stem Cell Therapy Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Stem Cell Therapy Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Stem Cell Therapy Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Stem Cell Therapy Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Stem Cell Therapy Market Competitive Analysis

    • 14.1 CELGENE CORPORATION

      • 14.1.1 CELGENE CORPORATION Company Details

      • 14.1.2 CELGENE CORPORATION Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 CELGENE CORPORATION Stem Cell Therapy Product and Service

    • 14.2 ReNeuron Group plc

      • 14.2.1 ReNeuron Group plc Company Details

      • 14.2.2 ReNeuron Group plc Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 ReNeuron Group plc Stem Cell Therapy Product and Service

    • 14.3 Virgin Health Bank

      • 14.3.1 Virgin Health Bank Company Details

      • 14.3.2 Virgin Health Bank Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Virgin Health Bank Stem Cell Therapy Product and Service

    • 14.4 Biovault family

      • 14.4.1 Biovault family Company Details

      • 14.4.2 Biovault family Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Biovault family Stem Cell Therapy Product and Service

    • 14.5 Precious Cells International Ltd

      • 14.5.1 Precious Cells International Ltd Company Details

      • 14.5.2 Precious Cells International Ltd Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Precious Cells International Ltd Stem Cell Therapy Product and Service

    • 14.6 Mesoblast Ltd

      • 14.6.1 Mesoblast Ltd Company Details

      • 14.6.2 Mesoblast Ltd Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Mesoblast Ltd Stem Cell Therapy Product and Service

    • 14.7 Astellas Pharma Inc

      • 14.7.1 Astellas Pharma Inc Company Details

      • 14.7.2 Astellas Pharma Inc Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Astellas Pharma Inc Stem Cell Therapy Product and Service

    • 14.8 Seneca Biopharmaceuticals, Inc

      • 14.8.1 Seneca Biopharmaceuticals, Inc Company Details

      • 14.8.2 Seneca Biopharmaceuticals, Inc Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Seneca Biopharmaceuticals, Inc Stem Cell Therapy Product and Service

    • 14.9 Opexa Therapeutics, Inc

      • 14.9.1 Opexa Therapeutics, Inc Company Details

      • 14.9.2 Opexa Therapeutics, Inc Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Opexa Therapeutics, Inc Stem Cell Therapy Product and Service

    • 14.10 Pluristem Therapeutics Inc

      • 14.10.1 Pluristem Therapeutics Inc Company Details

      • 14.10.2 Pluristem Therapeutics Inc Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Pluristem Therapeutics Inc Stem Cell Therapy Product and Service

    • 14.11 STEMCELL Technologies Inc

      • 14.11.1 STEMCELL Technologies Inc Company Details

      • 14.11.2 STEMCELL Technologies Inc Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 STEMCELL Technologies Inc Stem Cell Therapy Product and Service

    • 14.12 ThermoGenesis Holdings, Inc

      • 14.12.1 ThermoGenesis Holdings, Inc Company Details

      • 14.12.2 ThermoGenesis Holdings, Inc Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 ThermoGenesis Holdings, Inc Stem Cell Therapy Product and Service

    • 14.13 Chiesi Pharmaceuticals

      • 14.13.1 Chiesi Pharmaceuticals Company Details

      • 14.13.2 Chiesi Pharmaceuticals Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Chiesi Pharmaceuticals Stem Cell Therapy Product and Service

    • 14.14 Cellular Engineering Technologies

      • 14.14.1 Cellular Engineering Technologies Company Details

      • 14.14.2 Cellular Engineering Technologies Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Cellular Engineering Technologies Stem Cell Therapy Product and Service

    • 14.15 BioTime, Inc

      • 14.15.1 BioTime, Inc Company Details

      • 14.15.2 BioTime, Inc Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 BioTime, Inc Stem Cell Therapy Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Stem Cell Therapy

    • Figure Stem Cell Therapy Picture

    • Table Global Stem Cell Therapy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Stem Cell Therapy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Stem Cell Therapy Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Stem Cell Therapy Consumption by Country (2017-2022)

    • Figure United States Stem Cell Therapy Consumption and Growth Rate (2017-2022)

    • Table Europe Stem Cell Therapy Consumption and Growth Rate (2017-2022)

    • Figure China Stem Cell Therapy Consumption and Growth Rate (2017-2022)

    • Figure Japan Stem Cell Therapy Consumption and Growth Rate (2017-2022)

    • Figure India Stem Cell Therapy Consumption and Growth Rate (2017-2022)

    • Figure South Korea Stem Cell Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Stem Cell Therapy Consumption Forecast by Country (2022-2028)

    • Figure United States Stem Cell Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Stem Cell Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Stem Cell Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Stem Cell Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Stem Cell Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Stem Cell Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autologous Consumption and Growth Rate (2017-2022)

    • Figure Global Allogeneic Consumption and Growth Rate (2017-2022)

    • Figure Global Musculoskeletal Disorder Consumption and Growth Rate (2017-2022)

    • Figure Global Wounds & Injuries Consumption and Growth Rate (2017-2022)

    • Figure Global Cornea Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Autologous Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Allogeneic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Musculoskeletal Disorder Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Wounds & Injuries Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cornea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Stem Cell Therapy Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Stem Cell Therapy Export by Region (Top 5 Countries) (2017-2028)

    • Table CELGENE CORPORATION (Foundation Year, Company Profile and etc.)

    • Table CELGENE CORPORATION Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table CELGENE CORPORATION Stem Cell Therapy Product and Service

    • Table ReNeuron Group plc (Foundation Year, Company Profile and etc.)

    • Table ReNeuron Group plc Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table ReNeuron Group plc Stem Cell Therapy Product and Service

    • Table Virgin Health Bank (Foundation Year, Company Profile and etc.)

    • Table Virgin Health Bank Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Virgin Health Bank Stem Cell Therapy Product and Service

    • Table Biovault family (Foundation Year, Company Profile and etc.)

    • Table Biovault family Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biovault family Stem Cell Therapy Product and Service

    • Table Precious Cells International Ltd (Foundation Year, Company Profile and etc.)

    • Table Precious Cells International Ltd Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Precious Cells International Ltd Stem Cell Therapy Product and Service

    • Table Mesoblast Ltd (Foundation Year, Company Profile and etc.)

    • Table Mesoblast Ltd Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mesoblast Ltd Stem Cell Therapy Product and Service

    • Table Astellas Pharma Inc (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Inc Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Inc Stem Cell Therapy Product and Service

    • Table Seneca Biopharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Seneca Biopharmaceuticals, Inc Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Seneca Biopharmaceuticals, Inc Stem Cell Therapy Product and Service

    • Table Opexa Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Opexa Therapeutics, Inc Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Opexa Therapeutics, Inc Stem Cell Therapy Product and Service

    • Table Pluristem Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Pluristem Therapeutics Inc Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pluristem Therapeutics Inc Stem Cell Therapy Product and Service

    • Table STEMCELL Technologies Inc (Foundation Year, Company Profile and etc.)

    • Table STEMCELL Technologies Inc Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table STEMCELL Technologies Inc Stem Cell Therapy Product and Service

    • Table ThermoGenesis Holdings, Inc (Foundation Year, Company Profile and etc.)

    • Table ThermoGenesis Holdings, Inc Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table ThermoGenesis Holdings, Inc Stem Cell Therapy Product and Service

    • Table Chiesi Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Chiesi Pharmaceuticals Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chiesi Pharmaceuticals Stem Cell Therapy Product and Service

    • Table Cellular Engineering Technologies (Foundation Year, Company Profile and etc.)

    • Table Cellular Engineering Technologies Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cellular Engineering Technologies Stem Cell Therapy Product and Service

    • Table BioTime, Inc (Foundation Year, Company Profile and etc.)

    • Table BioTime, Inc Stem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioTime, Inc Stem Cell Therapy Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US